Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) Return on Sales (2019 - 2025)

Korro Bio (KRRO) has disclosed Return on Sales for 6 consecutive years, with 16.57% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales changed N/A year-over-year to 16.57%, compared with a TTM value of 12.0% through Sep 2025, changed N/A, and an annual FY2024 reading of 36.8%, changed N/A over the prior year.
  • Return on Sales was 16.57% for Q3 2025 at Korro Bio, up from 17.65% in the prior quarter.
  • Across five years, Return on Sales topped out at 154.17% in Q2 2023 and bottomed at 17.65% in Q2 2025.
  • Average Return on Sales over 5 years is 22.79%, with a median of 4.38% recorded in 2021.
  • The sharpest move saw Return on Sales skyrocketed 7834bps in 2023, then tumbled -941bps in 2024.
  • Year by year, Return on Sales stood at 6.02% in 2021, then plummeted by -55bps to 9.31% in 2022, then skyrocketed by 101bps to 0.07% in 2023, then plummeted by -13355bps to 9.33% in 2024, then plummeted by -78bps to 16.57% in 2025.
  • Business Quant data shows Return on Sales for KRRO at 16.57% in Q3 2025, 17.65% in Q2 2025, and 9.17% in Q1 2025.